Parmax Pharma Ltd.

BSE: 540359

₹59.32

up-down-arrow2.82 (4.99%)

As on 12-Jun-2026IST

Market cap

info icon

₹22 Cr

Revenue (TTM)

info icon

₹12 Cr

P/E Ratio

info icon

--

P/B Ratio

info icon

-3.2

Div. Yield

info icon

0 %

Parmax Pharma Share Price

Compare

High:loading Low:loading Return: loading

Max:loading Min:loading Median:loading

Max:loading Min:loading Median:loading

loading...
loading...
loading...
loading...
loading...
loading...
loading...
loading...

Stock Range

Today’s Range

Low: 59.32 High: 59.32

52 Week Range

Low: 22.60 High: 59.32

Liquidityliquidity Low

Low Moderate High

Fundamentals

  • Net Profit (TTM)Net Profit (TTM) information

    ₹-4 Cr

  • ROEROE information

    0 %

  • ROCEROCE information

    -29.9 %

  • Industry P/EIndustry P/E information

    53.31

  • EV/EBITDAEV/EBITDA information

    -9.2

  • Debt to EquityDebt to Equity information

    -1.9

  • Book ValueBook Value information

    ₹-18.3

  • EPSEPS information

    ₹-11.1

  • Face valueFace value information

    10

  • Shares outstandingShares outstanding information

    3,741,300

10 Years Aggregate

CFO

₹10.57 Cr

EBITDA

₹8.98 Cr

Net Profit

₹-6.56 Cr

Performance

Company
YTD
1 Month
3 Months
1 Year
3 Years
5 Years
10 Years
Parmax Pharma
75.3 81.2 105.6 52.3 26.1 -3.8 --
BSE Commodities
6.1 -1.4 7.2 9.1 16.2 10.1 15.4
As on 12-Jun-2026
Company
2025
2024
2023
2022
2021
Parmax Pharma
-23.5 36.3 -15.8 -35.4 111.0
BSE Small Cap
-6.6 29.0 47.5 -1.8 62.8
BSE Commodities
12.5 8.1 17.5 1.2 61.5

Essential Checks

View Details

Is there a threat to the company's solvency?

Can creative accounting be detected through the financial numbers?

How did the company perform in the last one year?

Financials

View Details
loading...

*All values are in (₹ Cr)

loading...

*All values are in (₹ Cr)

loading...

*All values are in (₹ Cr)

Key Ratios

View Details
loading...

loading...

loading...

5Y Avg -- 3Y Avg -- TTM --

loading...

P/E Ratio

--

--Min --Median --Max

loading...

P/B Ratio

--

--Min --Median --Max

loading...

Earnings Yield (%)

--

Earnings Yield (%) = EBIT / Enterprise value

PEG Ratio

--

Price = Price / Earnings to growth ratio

loading...

loading...

loading...

Peers

View Details
Company
Price (₹) Market Cap (₹ Cr) Revenue (TTM) Net Profit (TTM) OPM (%) ROE (%) P/E P/B
Parmax Pharma
59.3 22.2 12.1 -4.2 -38.0 -- -- -3.2
440.6 15,974.7 8,302.0 419.0 8.3 7.1 38.1 2.7
1,142.9 15,183.2 1,153.5 219.5 25.6 9.5 69.2 6.2
3,168.4 14,452.2 3,621.0 1,973.8 12.0 16.8 7.3 5.9
1,669.9 22,779.0 7,887.1 550.7 9.6 9.9 41.4 3.9
4,724.7 14,483.6 2,365.8 420.2 18.0 16 34.7 5.4
680.5 34,316.4 4,660.7 755.1 19.2 18.1 45.7 7.3
IEL
5.5 71.9 1.0 0.2 -7.0 0.4 390.5 1.6
216.5 17,500.6 8,051.9 575.8 9.3 8.8 29.7 2.6
157.5 50.1 35.7 5.8 15.0 14.6 8.6 1.2

Shareholding Pattern

View Details
loading...
These are advertorial stories which keeps Value Research free for all. Click here to mark your interest for an ad-free experience in a paid plan

News & Analysis

All News

No Review & Analysis are available.

About Parmax Pharma

Manufacture of allopathic pharmaceutical preparations

  • Incorporated

    1994

  • Chairman

    --

  • Managing Director

    Umang A Gosalia

  • Headquarters

    Rajkot, Gujarat

  • Website

    www.parmaxpharma.com

Edit peer-selector-edit
loading...
loading...

FAQs for Parmax Pharma

The share price of Parmax Pharma Ltd is ₹59.32 (BSE) as of 12-Jun-2026 IST. Parmax Pharma Ltd has given a return of 26.13% in the last 3 years.

Since, TTM earnings of Parmax Pharma Ltd is negative, P/E ratio is not available.
The P/B ratio of Parmax Pharma Ltd is -3.24 times as on 12-Jun-2026, a 137 discount to its peers’ median range of 8.69 times.


PE & PB ratio at the end of financial year.


Year P/E Ratio P/B Ratio
2025
0.00
-5.86
2024
0.00
-17.63
2023
0.00
2.39
2022
108.00
3.43
2021
17.61
3.39

The 52-week high and low of Parmax Pharma Ltd are Rs 59.32 and Rs 22.60 as of 13-Jun-2026.

Parmax Pharma Ltd has a market capitalisation of ₹ 22 Cr as on 12-Jun-2026. As per SEBI classification, it is a Small Cap company.

Before investing in Parmax Pharma Ltd, assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.

For guidance, explore our expert-curated portfolios and Stock recommendations with Value Research Stock Advisor.
Want to explore on your own? Click here to see how this stock scores on quality, growth, valuation, and momentum.